Actively Recruiting
Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2025-09-02
100
Participants Needed
1
Research Sites
204 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study wants to evaluate the use of MRI in the managemente of mCRC with liver only metastases.
CONDITIONS
Official Title
Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18 years
- Histological diagnosis of colorectal cancer
- Presence of liver metastases in staging exams (chest-abdomen CT with contrast or PET-CT with 18-FDG)
- At least one measurable liver lesion according to RECIST 1.1 criteria
- Adequate organ and marrow function
You will not qualify if you...
- Age < 18 years
- Inability to undergo MRI
- Major contraindications to liver surgery
- No written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Policlinico Agostino Gemelli
Roma, Italy
Actively Recruiting
Research Team
L
Lisa Salvatore, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here